IL-17A in the tumor microenvironment of the human colorectal adenoma–carcinoma sequence

References

• Fearon ER. Molecular genetic studies of the adenoma-carcinoma sequence. Adv Intern Med 1994;39:123–47.
   PubMedGoogle Scholar
• Cho KR, Vogelstein B. Genetic alterations in the adenoma–carcinoma sequence. Cancer 1992;70:1727–31.
   PubMed Web of Science ®Google Scholar
• Contasta I, Berghella AM, Pellegrini P, Adorno D. Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother Radiopharm 2003;18:549–57.
   PubMed Web of Science ®Google Scholar
• Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605–12.
   PubMed Web of Science ®Google Scholar
• Cui G, Goll R, Olsen T, Steigen SE, Husebekk A, Vonen B, Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum. Cancer Immunol Immunother 2007;56:985–95.
   PubMed Web of Science ®Google Scholar
• Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol 2005;28:187–96.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets 2008;9:375–80.
   PubMed Web of Science ®Google Scholar
• Kim S, Keku TO, Martin C, Galanko J, Woosley JT, Schroeder JC, Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res 2008;68:323–8.
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A, Goll R, Vonen B, Florholmen J. Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother 2009;58:1897–905.
   Google Scholar
• Xu T, Sun BC, Li Q, Hao XS. Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells. World J Gastroenterol 2005;11:3915–19.
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A, Goll R, Vonen B, Florholmen J. Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother 2009;58:1897–905.
   Google Scholar
• Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009;27:485–517.
   PubMed Web of Science ®Google Scholar
• Maniati E, Soper R, Hagemann T. Up for Mischief? IL-17/Th17 in the tumour microenvironment. Oncogene 2010;29:5653–62.
   PubMed Web of Science ®Google Scholar
• Olsen T, Rismo R, Cui G, Goll R, Christiansen I, Florholmen J. TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation. Cytokine 2011;56:633–40.
   PubMed Web of Science ®Google Scholar
• Rismo R, Olsen T, Cui G, Christiansen I, Florholmen J, Goll R. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Scand J Gastroenterol 2012;47:538–47.
   PubMed Web of Science ®Google Scholar
• Charles KA, Kulbe H, Soper R, Escorcio-Correia M, Lawrence T, Schultheis A, The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J Clin Invest 2009;119:3011–23.
   PubMed Web of Science ®Google Scholar
• He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD, IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol 2010;184:2281–8.
   PubMed Web of Science ®Google Scholar
• Martin-Orozco N, Dong C. The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr Opin Investig Drugs 2009;10:543–9.
   PubMed Web of Science ®Google Scholar
• Murugaiyan G, Saha B. Protumor vs antitumor functions of IL-17. J Immunol 2009;183:4169–75.
   PubMed Web of Science ®Google Scholar
• Muranski P, Boni A, Antony PA, Cassard L, Irvine KR, Kaiser A, Tumor-specific Th17-polarized cells eradicate large established melanoma. Blood 2008;112:362–73.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S, Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009;114:1141–9.
   PubMed Web of Science ®Google Scholar
• Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003;101:2620–7.
   PubMed Web of Science ®Google Scholar
• Liu J, Duan Y, Cheng X, Chen X, Xie W, Long H, IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011;407:348–54.
   PubMed Web of Science ®Google Scholar
• Yang S, Wang B, Guan C, Wu B, Cai C, Wang M, Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol 2011;89:85–91.
   PubMed Web of Science ®Google Scholar
• Chae WJ, Gibson TF, Zelterman D, Hao L, Henegariu O, Bothwell AL. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proc Natl Acad Sci USA 2010;107:5540–4.
   PubMed Web of Science ®Google Scholar
• Wu S, Rhee KJ, Albesiano E, Rabizadeh S, Wu X, Yen HR, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat Med 2009;15:1016–22.
   PubMed Web of Science ®Google Scholar
• Nam JS, Terabe M, Kang MJ, Chae H, Voong N, Yang YA, Transforming growth factor beta subverts the immune system into directly promoting tumor growth through interleukin-17. Cancer Res 2008;68:3915–23.
   PubMed Web of Science ®Google Scholar
• Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY. Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis 2012;33(4):931–6.
   PubMed Web of Science ®Google Scholar
• Le Gouvello S, Bastuji-Garin S, Aloulou N, Mansour H, Chaumette MT, Berrehar F, High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas. Gut 2008;57:772–9.
   PubMed Web of Science ®Google Scholar
• Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G, Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011;71:1263–71.
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A, Vonen B, Florholmen J. Progressive cellular response in the lamina propria of the colorectal adenoma-carcinoma sequence. Histopathology 2009;54:550–60.
   PubMed Web of Science ®Google Scholar
• Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol 2007;19:409–17.
   PubMed Web of Science ®Google Scholar
• Dong C. Differentiation and function of pro-inflammatory Th17 cells. Microbes Infect 2009;11:584–8.
   PubMed Web of Science ®Google Scholar
• Kryczek I, Wei S, Szeliga W, Vatan L, Zou W. Endogenous IL-17 contributes to reduced tumor growth and metastasis. Blood 2009;114:357–9.
   PubMed Web of Science ®Google Scholar
• Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003;52:65–70.
   PubMed Web of Science ®Google Scholar
• Nielsen OH, Kirman I, Rudiger N, Hendel J, Vainer B. Upregulation of interleukin-12 and -17 in active inflammatory bowel disease. Scand J Gastroenterol 2003;38:180–5.
   PubMed Web of Science ®Google Scholar
• Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles C, Rampton DS, Differential regulation of interleukin-17 and interferon-{gamma} production in inflammatory bowel disease. Gut 2009;58:1629–36.
   PubMed Web of Science ®Google Scholar
• Abraham C, Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1090–100.
   PubMed Web of Science ®Google Scholar
• Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg 2002;89:845–60.
   PubMed Web of Science ®Google Scholar
• Wågsäter D, Lofgren S, Hugander A, Dimberg J. Expression of interleukin-17 in human colorectal cancer. Anticancer Res 2006;26:4213–16.
   PubMed Web of Science ®Google Scholar
• Fox SH, Whalen GF, Sanders MM, Burleson JA, Jennings K, Kurtzman S, Angiogenesis in normal tissue adjacent to colon cancer. J Surg Oncol 1998;69:230–4.
   PubMed Web of Science ®Google Scholar
• Pandey S, Gordon PH, Wang E. Expression of proliferation-specific genes in the mucosa adjacent to colon carcinoma. Dis Colon Rectum 1995;38:462–7.
   PubMed Web of Science ®Google Scholar
• Cui G, Yuan A, Goll R, Olsen T, Husebekk A, Vonen B, Distinct changes of dendritic cell number and IL-12 mRNA level in adjacent mucosa throughout the colorectal adenoma-carcinoma sequence. Cancer Immunol Immunother 2007;56:1993–2001.
   PubMed Web of Science ®Google Scholar
• Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999;59:3698–704.
   PubMed Web of Science ®Google Scholar
• Wang L, Yi T, Kortylewski M, Pardoll DM, Zeng D, Yu H. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009;206:1457–64.
   PubMed Web of Science ®Google Scholar
• Inozume T, Hanada K, Wang QJ, Yang JC. IL-17 secreted by tumor reactive T cells induces IL-8 release by human renal cancer cells. J Immunother 2009;32:109–17.
   PubMed Web of Science ®Google Scholar
• Tong Z, Yang XO, Yan H, Liu W, Niu X, Shi Y, A protective role by interleukin-17F in colon tumorigenesis. PLoS One 2012;7:e34959.
   PubMed Web of Science ®Google Scholar